127 related articles for article (PubMed ID: 31561109)
1. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.
Hu Y; Wang B; Yang J; Liu T; Sun J; Wang X
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):15-30. PubMed ID: 30362362
[TBL] [Abstract][Full Text] [Related]
5. New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
Basyouni WM; Abbas SY; El Shehry MF; El-Bayouki KAM; Aly HF; Arafa A; Soliman MS
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027251
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
[TBL] [Abstract][Full Text] [Related]
8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
9. New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
Abbas SY; Basyouni WM; El-Bayouk KAM; Tohamy WM; Aly HF; Arafa A; Soliman MS
Drug Res (Stuttg); 2017 Oct; 67(10):557-563. PubMed ID: 28651259
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies.
Bairagi KM; Younis NS; Emeka PM; Sangtani E; Gonnade RG; Venugopala KN; Alwassil OI; Khalil HE; Nayak SK
Med Chem; 2020; 16(7):996-1003. PubMed ID: 31880253
[TBL] [Abstract][Full Text] [Related]
11. Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats.
Xie M; Chen D; Zhang F; Willsky GR; Crans DC; Ding W
J Inorg Biochem; 2014 Jul; 136():47-56. PubMed ID: 24747360
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.
Salem MG; Aziz YMA; Elewa M; Elshihawy HA; Said MM
Bioorg Med Chem; 2019 Aug; 27(15):3383-3389. PubMed ID: 31221611
[TBL] [Abstract][Full Text] [Related]
13. Development and Characterization of a Glimepiride-Loaded Gelatin-Coated Mesoporous Hollow Silica Nanoparticle Formulation and Evaluation of Its Hypoglycemic Effect on Type-2 Diabetes Model Rats.
Yu X; Liu T; Lin R
Assay Drug Dev Technol; 2020; 18(8):369-378. PubMed ID: 33136434
[No Abstract] [Full Text] [Related]
14. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
Kharbanda C; Alam MS; Hamid H; Javed K; Dhulap A; Bano S; Ali Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4601-5. PubMed ID: 26384286
[TBL] [Abstract][Full Text] [Related]
16. Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Yang SJ; Je Lee W; Kim EA; Dal Nam K; Hahn HG; Young Choi S; Cho SW
Eur J Pharmacol; 2014 Aug; 736():26-34. PubMed ID: 24797782
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of phenylfuroxan nitric oxide-donor phenols as potential anti-diabetic agents.
Xie YD; Shao LH; Wang QT; Bai Y; Li N; Yang G; Li YP; Bian XL
Bioorg Chem; 2019 Aug; 89():103000. PubMed ID: 31132604
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats.
Nain P; Saini V; Sharma S; Nain J
J Ethnopharmacol; 2012 Jun; 142(1):65-71. PubMed ID: 22855943
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles.
Soliman R; Mokhtar H; Mohamed HF
J Pharm Sci; 1983 Sep; 72(9):999-1004. PubMed ID: 6631713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
